#biotechne

Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation, a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics. The partnership significantly expands global access to Spear Bio’s groundbreaking…

Bio-Techne Corp (TECH) CEO Charles Kummeth on Q3 2019 Results – Earnings Call Transcript

[unable to retrieve full-text content]

Bio-Techne Corp (NASDAQ:TECH) Q3 2019 Earnings Conference … customers enthusiasm for ACD technology is the recent strategic … Diagnostics. A Chinese high-tech company that develops diagnostics assays … an update on the Quad Tech acquisition? admittedly, gets less …… Technology News

Bio-Techne Corp (TECH) CEO Charles Kummeth on Q3 2019 Results – Earnings Call Transcript

[unable to retrieve full-text content]

Bio-Techne Corp (NASDAQ:TECH) Q3 2019 Earnings Conference … customers enthusiasm for ACD technology is the recent strategic … Diagnostics. A Chinese high-tech company that develops diagnostics assays … an update on the Quad Tech acquisition? admittedly, gets less …… Technology News

Bio-Techne Corp (TECH) CEO Charles Kummeth on Q3 2019 Results – Earnings Call Transcript

[unable to retrieve full-text content]

Bio-Techne Corp (NASDAQ:TECH) Q3 2019 Earnings Conference … customers enthusiasm for ACD technology is the recent strategic … Diagnostics. A Chinese high-tech company that develops diagnostics assays … an update on the Quad Tech acquisition? admittedly, gets less …… Technology News

Bio-Techne Corp. (TECH) CEO Chuck Kummeth on Q2 2019 Results – Earnings Call Transcript

[unable to retrieve full-text content]

Bio-Techne Corp. (NASDAQ:TECH) Q2 2019 Earnings Conference Call … billion in superior RNA ISH technology in situ hybridization, nothing less … . So this too is a technology that is incredible science and …… Technology News

The Link.